List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 8 studies with search of: CPG-7909 [TREATMENT] AND lymphoma [CONDITION]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)
Conditions: Melanoma;   Breast Neoplasms;   Carcinoma, Renal Cell;   Lymphoma, T-Cell;   Carcinoma, Non-Small-Cell Lung
Intervention: Drug: PF-3512676
2 Completed CPG 7909 in Patients With Cutaneous T-Cell Lymphoma
Condition: Lymphoma, T-Cell, Cutaneous
Intervention: Drug: PF-3512676
3 Active, not recruiting CpG 7909 in Treating Patients With Cutaneous T-Cell Lymphoma
Condition: Lymphoma
Intervention: Drug: agatolimod sodium
4 Active, not recruiting CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant
Conditions: Germ Cell Tumor;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Biological: keyhole limpet hemocyanin;   Biological: tetanus toxoid;   Drug: agatolimod sodium;   Other: immunoenzyme technique;   Other: immunologic technique
5 Recruiting CpG 7909, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Treatment
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: agatolimod sodium;   Other: biomarker analysis;   Other: flow cytometry;   Other: immunologic technique;   Other: laboratory biomarker analysis;   Procedure: radionuclide imaging;   Procedure: single photon emission computed tomography;   Radiation: indium In 111 ibritumomab tiuxetan;   Radiation: yttrium Y 90 ibritumomab tiuxetan
6 Active, not recruiting Phase I/II CPG 7909 + Local XRT in Recurrent Low-Grade Lymphomas
Condition: Lymphoma, Non-Hodgkin
Interventions: Drug: CPG 7909;   Procedure: Local radiation
7 Terminated Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides.
Condition: Mycosis Fungoides
Intervention: Drug: CPG 7909
8 Active, not recruiting Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: agatolimod sodium

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services